Rare diseases
Investigational molecules
Locations
Back to Portugal638 clinical trials in Lisbon, Portugal across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction
PortugalStudy Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
PortugalStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
PortugalStudy of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections
PortugalStudy on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer
PortugalStudy Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer
PortugalStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
PortugalStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
PortugalStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
PortugalStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PortugalStudy Comparing Lazertinib and Subcutaneous Amivantamab with Intravenous Amivantamab for Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer
PortugalSafety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on head and neck cancer treatments and advanced lung cancer therapies, combining novel approaches with standard treatments.
Studies evaluate targeted therapies and immunotherapy combinations to improve patient outcomes.
Comprehensive research into various autoimmune disorders, with particular focus on psoriasis and systemic sclerosis treatments.
Testing innovative biological therapies and novel treatment approaches.
Studies examining treatments for Dravet Syndrome and Alzheimer's-related psychosis, focusing on improving patient quality of life.
Investigating new therapeutic options for challenging neurological conditions.
Research targeting Crohn's Disease and various inflammatory conditions, evaluating new treatment combinations.
Testing advanced therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
